I was always a big fan of - and have seen good outcomes with - using Naltrexone implants for opioid addicts in early recovery. While it has been subjected to broad clinical trials and used by private clinics here and abroad, it has not been approved by the FDA. Due to some of the publicized concerns associated with its use it hasn’t been widely accepted and finding physicians with experience administering implants has been more difficult in the U.S. than those willing to prescribe opioid maintenance. Some of the complaints have included a secondary sensitivity of opioid receptors that has led to overdoses once treatment has been terminated. While concerns are not affected by the method of administration, the newly approved IM Vivitrol injection approved by the FDA may standardize its application and treatment precautions giving providers additional treatment options. Read Full Story